Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Biological Chemistry|August 11, 2000
Theoretical description of the direct exponential amplification and sequencing (DEXAS) methodM Ingr, J KonvalinkaCurrent Medicinal Chemistry|February 7, 2012
GCPII variants, paralogs and orthologsK Hlouchová, V Navrátil, J Tykvart, et al.Amino Acids|August 17, 2004
Synthesis and application of methyleneoxy pseudodipeptide building blocks in biologically active peptidesJ Hlavácek, J Marík, J Konvalinka, et al.Protein Science : a Publication of the Protein Society|October 25, 2000
Systematic mutational analysis of the active-site threonine of HIV-1 proteinase: rethinking the "fireman's grip" hypothesisK Strisovsky, U Tessmer, J Langner, et al.Antimicrobial Agents and Chemotherapy|August 15, 2001
Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activityK Lindsten, T Uhlíková, J Konvalinka, et al.Journal of Virology|November 1, 1995
Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyproteinJ Konvalinka, M Löchelt, H Zentgraf, et al.Journal of Virology|June 1, 1995
The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivityH G Kräusslich, M Fäcke, A M Heuser, et al.Biochemical and Biophysical Research Communications|May 6, 1996
A modular approach to HIV-1 proteinase inhibitor designT Uhlíková, J Konvalinka, I Pichová, et al.Protein Expression and Purification|December 20, 2011
Efficient and versatile one-step affinity purification of in vivo biotinylated proteins: expression, characterization and structure analysis of recombinant human glutamate carboxypeptidase IIJ Tykvart, P Sácha, C Bařinka, et al.European Journal of Biochemistry|July 15, 1994
A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral proteaseJ Freund, R Kellner, J Konvalinka, et al.Pageof 3